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ABSTRACT: To overcome the recent outbreaks of hepatotoxicity-related drugs, a new
analytical tool for the continuously determination of these drugs in human ﬂuids is
required. Electrochemical-based analytical methods oﬀer an eﬀective, rapid, and simple tool
for on-site determination of various organic and inorganic species. However, the design of a
sensitive, selective, stable, and reproducible sensor is still a major challenge. In the present
manuscript, a facile, one-pot hydrothermal synthesis of bismuth oxide (Bi2O2.33)
nanostructures (nanorods) was developed. These BiO nanorods were cast onto mass
disposable graphite screen-printed electrodes (BiO-SPEs), allowing the ultrasensitive
determination of acetaminophen (APAP) in the presence of its common interference
isoniazid (INH), which are both found in drug samples. The simultaneous electroanalytical
sensing using BiO-SPEs exhibited strong electrocatalytic activity toward the sensing of
APAP and INH with an enhanced analytical signal (voltammetric peak) over that
achievable at unmodiﬁed (bare) SPEs. The electroanalytical sensing of APAP and INH are
possible with accessible linear ranges from 0.5 to 1250 μM and 5 to 1760 μM with limits of
detection (3σ) of 30 nM and 1.85 μM, respectively. The stability, reproducibility, and repeatability of BiO-SPE were also
investigated. The BiO-SPEs were evaluated toward the sensing of APAP and INH in human serum, urine, saliva, and tablet
samples. The results presented in this paper demonstrate that BiO-SPEs sensing platforms provide a potential candidate for the
accurate determination of APAP and INH within human ﬂuids and pharmaceutical formulations.
Hepatotoxicity implies chemical-driven liver damage andthe liver acts as the central organ for metabolism of
virtually every foreign substance (i.e., drugs).1 More than 900
drugs and herbs have been reported to cause severe liver
disease and drugs account for 20−40% of all instances of
fulminant hepatic failure. Approximately 75% of the idiosyn-
cratic drug reactions result in liver transplantation or death.2
Drug-induced liver disease is responsible for 5% of all hospital
admissions and 50% of all acute liver failures in western
countries.3 Therefore, physicians must be vigilant in identifying
drug-related hepatic injury because early detection can reduce
the severity of induced hepatotoxicity. Knowledge of the
commonly implicated drugs is essential in clinical diagnosis. In
the United States, approximately 2000 cases of acute liver
failure occur annually and nearly 60% of these are caused by
acetaminophen or idiosyncratic drug reactions.4 Development
of an analytical tool for accurate determination of acetamino-
phen (APAP) and its interferences has a signiﬁcant importance
not only in clinical diagnosis but also for quantity control of
their pharmaceutical formulations.
Acetaminophen, APAP (N-acetyl-p-aminophenol) is known
as Paracetamol or Tylenol and is one of the most widely
antipyretic and analgesic drugs these days. It is an extremely
weak acid (pKa = 9.7) and is, therefore, essentially un-ionized at
physiological pH values. It is commonly used as a safe and
eﬀective painkiller associated with headache, backache, arthritis,
and postoperative pain. It has also been used for reduction of
cough, cold, and fevers symptoms.5 The analgesic−antipyretic
eﬀect of APAP is similar to aspirin, but APAP is normally
preferred, especially for the patients who are sensitive to
acetylsalicylic acid.6 The mechanism of action of APAP to
relieve pain is linked to inhibition of prostaglandin synthesis in
the central nervous system and relieves fever by sedating
hypothalamic heat-regulating center.7 Single doses of APAP
shows analgesic activity in a variety of acute pain syndromes
without any side eﬀects; however, overdoses (4.0 g/daily) are
now the most common cause of acute liver failure, which may
progress to death. Therapeutic concentration levels in plasma is
between 10 and 25 μg/mL, however, its toxicity concentration
level is higher than 200 μg/mL (≈1.33 mM). It is therefore
important to develop an analytical technique to determine
acetaminophen in pharmaceutical dosages and human ﬂuids
accurately. A variety of analytical methods such as titrimetry,8
UV/vis spectrophotometry,9 ﬂow-injection,10 high performance
liquid chromatography (HPLC),11 chemiluminescence,12 capil-
Received: December 27, 2016
Accepted: January 6, 2017
Published: January 6, 2017
Article
pubs.acs.org/ac
© 2017 American Chemical Society 2170 DOI: 10.1021/acs.analchem.6b05130
Anal. Chem. 2017, 89, 2170−2178
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
lary electrophoresis (CE),13 and electrochemical techni-
ques14−16 have been recently reported. While, improving the
analytical method in terms of sensitivity, stability, repeatability,
and selectivity are essential for human health and security.17
Isoniazid (isonicotinoyl hydrazine, INH) is an antibacterial
drug available as more than 300 mg tablets for oral
administration. It is one of eﬀective tuberculostatic drugs
widely used for prevention and treatment of tuberculosis due to
restriction of mycobacterium strains18,19 and is an essential and
indispensable basic remedy for tuberculosis. However, it is
associated with hepatotoxicity and peripheral neuropathy while
slow acetylators may be at increased risk of toxicity. The
toxicity can occur with the acute ingestion of as little as 1.5 g
(10.9 mM). Moreover, hydrazine was produced during the
isoniazid metabolism not only inducing hepatotoxicity with
inﬂammation but also might lead to death.20 The Public Health
Service Surveillance Study examined 13838 patients treated
with INH in the U.S.A.; there were eight deaths among 174
cases of hepatitis. Furthermore, some antipyretic drugs like
APAP should be combined with INH to control fever during
the course of disease. This combination enhances drug−drug
interactions, ultimately aﬀecting their bioavailability and
pharmacokinetic behaviors. Such interaction might also
increase the extent of bioactive drug resulting in its toxic
eﬀects or decrease it to subtherapeutic levels in blood that may
lead to antimicrobial resistance. The pretreatment with INH
could increase the APAP-induced hepatic necrosis score by
85%.21 Therefore, the people taking INH and APAP are at risk
of APAP-toxicity.22 The patients treated with INH should be
carefully monitored and interviewed periodically every month
intervals. HPLC,23 spectrophotometry,24 chemiluminescence,25
CE,26 and electrochemical technique27,28 have been reported
recently for determination of INH. Although electrochemical
methods oﬀer fast response, easy handling, and low operating
cost, there is only one literature report detailing the
simultaneous determination of APAP and INH using
thionine-immobilized multiwalled carbon nanotube modiﬁed
carbon paste electrode.29 However, the cost-eﬀective, port-
ability, and diﬃculty to use such electrodes leads us to explore a
new generation of screen-printed electrodes in a form of a
point-of-care sensor.
Herein, we explored the simultaneous voltammetric deter-
mination of APAP and its common interference of INH using
BiO nanostructure-modiﬁed screen-printed electrodes (SPEs).
One-pot hydrothermal synthesis of BiO nanostructures has
been developed for the ﬁrst time. The dispersed BiO nanorods
are simply drop-casted onto SPE surfaces after which the
sensors are ready to be utilized. The BiO-SPEs are found to
exhibit greater electrocatalytic activity, stability, and reprodu-
cibility for the simultaneous determination of APAP and INH
in aqueous pH 2 buﬀer solution over unmodiﬁed (bare) SPEs.
The suggested BiO-SPE electrochemical sensing platform was
successfully employed to detect the concentration of APAP and
INH in human ﬂuids and pharmaceutical formulations.
■ EXPERIMENTAL SECTION
All chemicals were used without any further puriﬁcation.
Bismuth nitrate (Bi(NO3)3, 99.9%) was obtained from Sigma-
Aldrich Company Ltd. Acetaminophen was kindly supplied by
Glopal Napi Pharmaceutical Co. (6th of October, Egypt) and
Isoniazid purchased from BDH Co., Ltd. All experiments were
performed in Britton Robinson (BR) buﬀer solutions
containing 0.05 M of each boric acid, phosphoric acid, and
acetic acid and 0.1 M sodium hydroxide was added to reach the
required pH value of the solution.
Synthesis of Bismuth Oxide Nanostructures. The
hydrothermal synthesis of bismuth oxide nanorods has been
developed using bismuth nitrate Bi(NO3)3 and ammonium
hydroxide (NH4OH, 28%) as starting precursors without using
any further additives or template-directing agents. In our
synthesis approach, 2.42 g of Bi(NO3)3 was dissolved in 50.0
mL of acidiﬁed deionized water. The transparent solution of
Bi(NO3)3 was introduced into a 100.0 mL Teﬂon-lined
stainless steel autoclave. Then, NH4OH solution was
introduced until a white precipitate was formed. The solution
mixture has a pH value of 2.2. The autoclave was sealed and
placed in an oven at 160 °C for 12 h for hydrothermal
treatment after which was then allowed to cool at room
temperature. After the hydrothermal process, a white
precipitate was collected and rinsed several times with
ethanol/water mixture to remove the remaining agents before
being dried at 50 °C. Finally, the large yield of bismuth oxide
nanorods was formed by calcination at 300 °C for 3 h.
Fabrication of Bismuth Oxide Modiﬁed Screen-
Printed Electrode. The SPEs were fabricated in-house with
appropriate stencil using a DEK 248 screen-printing machine
(DEK, Weymouth, U.K.). These electrodes have been used
extensively in previous studies For their fabrication, ﬁrst, a
carbon-graphite ink formulation (product code C2000802P2;
Gwent Electronic Materials Ltd., U.K.) was screen-printed onto
a polyester (Autostat, 250 μm thickness) ﬂexible ﬁlm (denoted
throughout as standard-SPEs); these electrodes have been used
extensively in other work.17,30−37 This layer was cured in a fan
oven at 60 °C for 30 min. Next, a silver/silver chloride
reference electrode was included by screen-printing Ag/AgCl
paste (product code C2040308D2; Gwent Electronic Materials
Ltd., U.K.) onto the polyester substrates and a second curing
step was undertaken where the electrodes were cured at 60 °C
for 30 min. Finally, a dielectric paste (product code
D2070423D5; Gwent Electronic Materials Ltd., U.K.) was
then printed onto the polyester substrate to cover the
connections. After a ﬁnal curing at 60 °C for 30 min, these
SPEs are ready to be used. These SPEs have been reported
previously and shown to exhibit a heterogeneous electron
transfer (HET) rate constant, ko, of about 10−3 cm s−1, as
measured using the [Ru(NH3)6]
3+/2+ redox probe.
The SPEs were modiﬁed with BiO nanostructures by a
simple drop-casting process. The BiO suspension was prepared
by dispersing 5.0 mg of BiO powder in 5.0 mL of deionized
water and then sonicated for 10 min. A total of 5.0 μL of the
BiO suspension was dropped onto the SPE surface and left it to
dry in an oven at 50 °C for 30 min.
Real Sample Analysis. Fresh human blood (5 mL) was
collected from healthy volunteers in the hospital of Sohag
University, with the aliquot of the sample collected in a test
tube. The collected blood sample was kept at room
temperature for 30 min and then centrifuged for 5 min at
3500 rpm. Finally, the supernatant serum sample was collected
in a new test tube and stored at 4 °C in a refrigerator when not
in use. The APAP and INH in low, medium and high
concentration levels have been spiked into blood serum sample.
Then, the recovery test was carried out by spiking of APAP and
INH in serum sample into 10 mL electrochemical cell
containing pH 2.0 B.R buﬀer and diﬀerential pulse voltammetry
(DPV) was recorded. A standard addition method was used to
determine the APAP and INH concentrations.
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The applicability of BiO-SPEs was also tested in several real
samples (human blood, urine, saliva and pharmaceutical
tablets). APAP and INH were injected to the real samples
and left for 1.0 h, stored at 4 °C in a refrigerator. For human
blood, the sample was centrifuged for 5 min at 3500 rpm. The
supernatant serum sample containing APAP and INH was
collected in a new test tube and the pH was adjusted to pH 2
using hydrochloric acid. Then, 100 μL of serum samples was
dropped onto three electrode conﬁguration cell of BiO-SPEs
working electrode. DPV was utilized, and the standard addition
method was used to determine the APAP and INH
concentration.
For urine and saliva samples, 300 μL of saliva or urine
samples was also injected with APAP and INH and stored at 4
°C in the refrigerator for 1.0 h. Then, the sample solution was
adjusted to pH 2 using HCl. A total of 100 μL of adjusted saliva
or urine samples was dropped onto the working electrode of
the BiO-SPEs and DPV was utilized.
A total of 10 tablets of APAP (Paracetamol, 500 mg) and
INH (Isocid forte, 200 mg) pharmaceutical formulations were
accurately weighed and ﬁnely ground in a mortar. A chosen
amount of these powders were transferred into a 100 mL
volumetric ﬂask. About 20 mL of ethanol was added, swirled,
and sonicated for 5 min. The volume of the sample was
completed to the mark and ﬁnally ﬁltered using ﬁne ﬁlter paper.
The ﬁrst portion of the ﬁltrate was rejected. A speciﬁc volume
of the stock solution of the drugs was diluted with deionized
water to obtain the suitable concentration. A 100 μL of a
particular concentration of APAP and INH solutions were
diluted by B.R. buﬀer pH 2 and dropped onto the BiO-SPEs
and compared with the standard concentrations of APAP and
INH drugs. The concentrations of APAP and INH were
measured by DPV method.
Characterization of Bismuth Oxide Nanostructures.
The morphology of the bismuth oxide sample was investigated
using ﬁeld emission scanning electron microscopy (FE-SEM,
JEOL model 6500). The bismuth oxide powder was ground
and ﬁxed onto a specimen stub using double-sided carbon tape.
To obtain high-resolution micrographs, a 10 nm Pt ﬁlm was
coated on the bismuth oxide using anion sputtering (Hitachi E-
1030) at room temperature. The SEM was operated at 15 keV
to obtain high-resolution SEM images. Further, transmission
electron microscopy (TEM) of BiO sample was performed
using a JEOL JEM microscope model 2100. TEM was
conducted at an acceleration voltage of 200 kV to obtain a
lattice resolution of 0.1 nm. TEM images were recorded using a
CCD camera. The BiO sample was dispersed in ethanol
solution by using an ultrasonic bath, and then dropped on a
copper grid. Prior to inserting the samples into the TEM
column, the grid was vacuum-dried for 20 min.
Wide-angle powder X-ray diﬀraction (XRD) was performed
by X-ray diﬀractometer (Model FW 1700 series, Philips,
Netherlands) using with monochromatic CuKα radiation (λ =
1.54 Å), employing a scanning rate of 0.06°/min and 2θ ranges
from 20° to 80°. The diﬀraction data were analyzed using PDF
software released in 1996.
The textural surface properties and pore size distribution was
determined by N2 adsorption/desorption isotherms at 77 K
with a BELSORP36 analyzer (JP. BEL Co., Ltd.). The speciﬁc
surface area (SBET) was calculated using the Brunauer−
Emmett−Teller (BET) method with multipoint adsorption
data from the linear segment of the N2 adsorption isotherm.
The pore size distribution was determined from the analysis of
desorption branch of isotherm using Barrett−Joyner−Halenda
(BJH) method.
The voltammetric measurements were carried out using
Autolab 302N potentiostat/galvanostat workstation and data
was controlled by NOVA software version 1.11.2 for Windows
7. Experiments were performed using 3 mm bismuth oxide
modiﬁed graphite screen-printed working electrode, platinum
counter electrode, and saturated calomel electrode (SCE)
reference electrode.
■ RESULTS AND DISCUSSION
Physicochemical Characterization of the Bismuth
Oxide Nanostructures. Bismuth oxide is an important
metal oxide semiconductor that has been intensively inves-
tigated due to excellent optical and electrical properties such as
wide band gap, high refractive index, high dielectric
permittivity, and good photoconductivity.38,39 Owing to these
unique features, it has been widely used in many applications
such as schottky barrier solar cells, sensor technology, varistors,
optical coatings, photovoltaic cells, microwave integrated
circuits, and transparent ceramic glass manufacturing.38,39
Control over the morphology, size, crystallinity, and surface
composition of bismuth oxide nanostructures can eﬀectively
alter its physicochemical characteristics. Herein, a simple, one-
pot hydrothermal synthesis of BiO nanostructures has been
carried out by adjusting the pH of acidic solution of bismuth
nitrate by ammonium hydroxide solution until a white
precipitate was formed. After which, calcination of obtained
white powder at 300 °C for 3.0 h was performed.
Although the particle morphology, composition, and size are
crucial factors for metal oxide nanostructures applicabil-
ity,30,30−42 very little literature has reported its ability to
control the size and morphology of bismuth oxide (Bi2O3)
nanostrucures.38,39,43 Figure 1A shows the SEM micrograph of
bismuth oxide sample synthesized by a facile one-pot
hydrothermal method without any additives. The SEM image
exhibits highly dispersed and nanosized bismuth oxide with
rod-like morphology. The average diameter of bismuth oxide
nanorods is about 50 nm with a length of 400 nm. Further,
TEM image (Figure 1B) shows dispersed BiO nanorods with
an average diameter of 50 nm and a length of about 300−400
nm. Signiﬁcantly, our synthesis conditions provide a facile and
template-free method for fabrication of highly crystalline
bismuth-rich bismuth oxide nanostructures without any
agglomeration.
The speciﬁc surface area and porosity of the BiO nanorods
were investigated by using N2 adsorption/desorption iso-
therms. Figure 2 shows a representative N2 adsorption/
desorption isotherm measured at 77 K and distribution of
Figure 1. (A) FE-SEM and (B) TEM images of BiO nanostructures
prepared via a simple hydrothermal treatment.
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pore diameter for the synthesized BiO sample. The N2
isotherm can be categorized as type IV with a distinct H3
hysteresis loop was observed in the range of 0.5−1.0 P/P0,
which was characteristic of macro-/ meso-porous materials.
The SBET speciﬁc surface area was calculated to be 7.9 m
2 g−1.
Further, the BiO nanorods contained small mesopores with
average diameter about 5, 34, and 55 nm, determined by using
the Barret−Joyner−Halenda (BJH) method (Figure 2B). The
formation of the lower pore size was probably related to the
pores present inside the nanorods, which were formed between
primary crystallites. In turn, the higher pore size may be related
to the voids between the nanorod particles. Such multi-modal
porous texture of BiO nanorods is very important in
electrochemical sensors because it provides enhanced surface
area with macro-/mesopores. These signiﬁcant features are the
key factors for controlling the diﬀusion pathway of analytes and
alter the solution/electrode interface. Furthermore, the crystal
structure of the bismuth oxide powder was characterized using
XRD and is shown in Figure 2B. Diﬀerent diﬀraction peaks
have been indexed with corresponding (hkl) values using
JCPDS data ﬁle (27−0051) indicating the nanocrystalline
structure of the bismuth oxide. The XRD patterns also
conﬁrmed preferential growth of tetragonal phases of
Bi2O2.33. Interestingly, the XRD shows stoichiometric changes
due to oxygen loss. The slight excess of Bi atoms over oxygen
atoms in the tetragonal crystal might oﬀer enhanced electron
conductivity for better electrochemical performance.
Electrochemical Characterization of Bismuth Oxide
Nanostructures. To explore the electrochemical performance
of (BiO-SPE), the redox probe of K3Fe(CN)6 has been studied.
Figures 3 and S1 show the cyclic voltammetric curves of BiO
modiﬁed and bare/unmodiﬁed screen printed-electrode in 2 ×
10−4 mol L−1 K3[Fe(CN)6]/0.1 mol L
−1 KCl recorded over a
range of voltammetric scan rates. In both cases, the peak
heights were increased with increasing the potential scan rate as
well as they are linearly correlated with the square root of the
scan rates in the range of 10−200 mV/s (as shown in Figure
3B), suggesting a diﬀusion controlled process of reactants at the
electrode surface. Comparing the CV curves at 10 mV/s, it was
found that the peak current ratio (Ipc/Ipa) is equal to 1.1 for the
unmodiﬁed SPEs, while the BiO-SPEs exhibit a Ipc/Ipa equal to
1.37. Therefore, the BiO-SPEs may be claimed to promote
electron transfer reaction better than the unmodiﬁed SPE does.
Moreover, the peak separation was slightly increased to 179 mV
at the BiO-SPEs compared to 170 mV for unmodiﬁed SPEs,
which is due to the electrostatic repulsion between [Fe-
(CN)6]
3− and BiO nanorod surface. This behavior suggests that
the BiO surface is more negatively charged, in agreement with
the behavior observed for Titanate nanotubes.40 The results
show in Figure 3 that the BiO nanorods have enhanced the
electrochemical signal/performance of the graphite screen-
printed electrode by an order of ∼2 times, which might be
attributed to the free bismuth atoms on the surface of BiO
nanoparticles that facilitated the electron transfer process and/
or an increase in the electrochemical surface area (i.e., the BiO
kinetics dominate).30
Electrochemical Behavior of APAP and INH. The
voltammetric behavior of APAP and INH were investigated
on BiO-SPEs because the isoniazid was considered as an
important drug interferes with APAP in pharmaceuticals. Figure
S2 illustrates the cyclic voltammograms of 75 μmol L−1 APAP
and 75 μmol L−1 INH obtained in B.R. Buﬀer solution (pH
2.0) on unmodiﬁed and BiO modiﬁed SPEs. BiO nanorods
showed an eﬃcient electrocatalytic activity for the oxidation of
APAP and INH molecules compared to bare SPEs. In order to
explore the eﬃciency of BiO nanorods, diﬀerent metal oxide
nanostructure materials and bismuth-based materials have been
synthesized and used for determination of APAP and INH
drugs. NiO,40 CuO,30 CdO,44 MgO,45 Bi2S3,
46 Bi12NiO19,
47 and
bulky Bi2O3 have been investigated (as shown in Figure S3).
Interestingly, BiO nanorods-SPEs show high sensitivity and
stability as well as good peak potential separation in the
determination of APAP and INH molecules. Figure 4A shows
cyclic voltammetry of successive additions individually of APAP
and INH in BR buﬀer pH 2.0 at scan rate of 50 mVs−1 on BiO-
SPEs. As it can be seen, APAP and INH exhibit well-deﬁned
oxidation peaks around 0.64 and 1.02 V, respectively. The peak
potentials diﬀerence of about 0.38 V (vs SCE) between both
oxidation peaks clearly allows the simultaneous determination
of APAP and INH without any interference. Of interest is the
Figure 2. (A) Nitrogen adsorption/desorption isotherm and its
corresponding BJH pore distribution curve; (B) Typical X-ray powder
diﬀraction pattern of the BiO nanostructures.
Figure 3. (A) Cyclic voltammetric curves of SPE and BiO-SPEs in 0.1
M KCl containing 2 × 10−4 M potassium ferricyanide. (B) Cyclic
voltammetric peak current analysis at various scan rates.
Figure 4. (A) Cyclic voltammetric curves observed at BiO nanorods
modiﬁed SPEs for successive additions of APAP and INH into B.R.
buﬀer pH 2. (B) Corresponding cyclic voltammetric peak current
analysis of APAP and INH additions at scan rate 50 mV s−1.
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voltammetric peak current response of APAP and INH on the
BiO-SPE linearly correlates with their concentrations up to 300
μmol L−1, as shown in Figure 4B.
Next attention was turned to explore the eﬀect of pH upon
the electrochemical signals of APAP and INH, since the
selection of suitable medium is very important for simultaneous
electrochemical responses of APAP and INH. Figure S4 shows
the cyclic voltammetric curves of 100 μM of APAP and 100 μM
INH onto BiO-SPEs in diﬀerent pH values in diﬀerent pH
values. Moreover, eﬀect of solution pHs on the CV curves for
50 μmol L−1 APAP and 50 μmol L−1 INH onto BiO-SPEs also
presented. With increasing the pH value, the oxidation
potentials of APAP and INH were shifted to less positive
potential values and the oxidation peak of INH interferes with
oxidation peak of APAP. This result indicates that, the pH 2 is
the suitable medium for simultaneous determination of APAP
and INH. A plot of peak potential (E) versus pH, as shown in
Figure S4D, was constructed where a linear range with gradient
of 43 mV/pH and 64 mV/pH for APAP and INH, respectively,
were observed (For APAP; E/V = 0.043 Ep (V)/pH + 0.55 V,
R2 = 0.95; For INH; E/V = 0.064 Ep (V)/pH + 0.83 V, R2 =
0.98). These values are close to that of Nernstian slope (59
mV/pH), which related to transfer an equal number of protons
and electrons and likely to be in agreement with the
literature.5,29,50−59 Therefore, we supposed that the oxidation
of APAP and INH at BiO-SPEs likely involves 2e−/2H+ transfer
processes, as shown in Scheme 1. In APAP, it was observed
that, the peak current of APAP was decreased in alkaline
solutions. The pKa value APAP in solution is about 9.7, above
this value the APAP was existed in deprotonated form which
exhibit a net negative charge. Such negative charge will be
repulsed with the negative charge of the BiO-SPE surface.
Moreover, the deprotonated APAP form is likely to be more
soluble in aqueous solution than its neutral species; hence, the
amount of diﬀused APAP to BiO-SPEs surface is much lower
than its fraction in the solution. Therefore, the acidic medium is
highly desirable for oxidation of APAP on BiO-SPEs. The
oxidation of APAP includes transfer of 2e−/2H+ to form
quinone-like structure followed by hydrolysis of the acetamide
functional group to produce p-aminophenol (Scheme 1).
Further, the pKa value of INH is about 4.84 and therefore,
protonated form of isoniazid will be also very important in the
electrostatic attraction with negatively charged BiO nanorods.
In alkaline medium, the oxidation peak was splitted to one-
electron coupled with one-proton reaction process for each of
these two peaks. The oxidation of INH on BiO-SPEs is
undergoing transfer of 2e−/2H+ and subsequently hydrolyses to
Isonicotinic acid. The optimal voltammetric response in Figure
S4C suggested that B.R. buﬀer pH 2 is a suitable supporting
electrolyte for determination of APAP and INH in real samples.
Next, the eﬀect of scan rates upon the electrochemical
oxidation behaviors of APAP and INH was explored in B.R.
buﬀer pH 2.0. Figure 5 shows the cyclic voltammetric proﬁles
of 100 μmol L−1 APAP and 100 μmol L−1 INH in pH 2 in
diﬀerent scan rate in the range of 10−300 mV s−1. No
reduction peak has been observed in the cyclic voltammograms
of INH. However, the intensity of APAP reduction peak
becomes signiﬁcant at higher scan rates. Meanwhile, there was a
positive shift of peak potential with the increase of scan rates.
The analysis of peak height against the square root of scan rate
was found to be linear indicating a diﬀusional controlled
processes (for APAP; Ipa/μA = 5.74 μA (V s
−1)−1/2 + 0.68 μA,
R2 = 0.992, For INH; Ipa/μA = 8.67 μA (V s
−1)−1/2 + 0.23 μA,
R2 = 0.997). Moreover, the linear relationship of log (Ipa) and
log υ can be expressed as follows; For APAP: log Ipa = 0.33 log
υ + 0.73, For INH: log Ipa/μA = 0.45 log υ + 0.925. The slope
values are very close to the theoretical value of 0.5, which
clearly indicates a diﬀusion controlled electrode process (rather
than a thin layer eﬀect). From the above results, the electro-
oxidation of APAP and INH can be described as in Scheme 1.
Electrochemical Determination of APAP and INH.
Next, DPV was employed to investigate the sensitivity of BiO-
SPEs in terms of linear ranges and the detection limits for the
APAP and INH drugs. The DPV experiments were recorded
using the following parameters; step potential 0.01 V,
modulation potential 0.025 V, modulation time 0.05 s, interval
time 0.2 s, scan rate 50 mV s−1, deposition time 5 s, and
equilibrium time 5 s. Figure 6 displays the DPV responses of
the electrochemical oxidation of APAP and INH using BiO-
SPEs in pH 2.0 of BR buﬀer under the optimized working
conditions. The peak height was increased with continuous
additions of APAP and INH solutions. For APAP, two linear
relationships were established (as shown in Figure 6B) in the
Scheme 1. Oxidation Mechanisms of APAP and INH at BiO-
SPEs Figure 5. Eﬀect of scan rate on cyclic voltammetric curves of 100 μM
of APAP (A and B) and 100 μM of INH (C and D) observed at BiO
nanorods modiﬁed SPEs in B.R. buﬀer pH 2.
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range of 0.5 to 97 μmol L−1 and 140 to 1250 μmol L−1 as Ip
(μA) = 0.027 μA μM−1 + 0.06 μA (R2 = 0.997) and Ip (μA) =
0.0034 μA μM−1 + 1.64 μA (R2 = 0.98), respectively. As well as
two linear segments of INH were also presented (as shown in
Figure 6D) in the range of 5−100 μmol L−1 and 144−1760
μmol L−1 as Ip (μA) = 0.008 μA μM
−1 − 0.009 μA (R2 = 0.99)
and Ip (μA) = 0.0012 μA μM
−1 + 0.49 μA (R2 = 0.98),
respectively. Based on the ﬁrst linear ﬁtting equations of APAP
and INH, the limits of detection were calculated to be 30 nmol
L−1 and 1.85 μmol L−1, respectively. The superior performance
of the BiO-SPEs suggests a promising platform for the
electrochemical determination of APAP and INH in real
samples.
As mentioned previously, simultaneous determination of
APAP and INH was studied in diﬀerent pH values, and B.R.
buﬀer pH 2.0 was selected as a suitable supporting electrolyte
solution. DPV experiments for simultaneous determination of
APAP and INH are carried out in pH 2.0, as represented in
Figure 7. DPV of successive additions of APAP in the presence
of 50 μmol L−1 INH revealed two well-separated and distinct
oxidation peaks of APAP and INH were observed (Figure 7A).
Interestingly, there was no signiﬁcant change of the
voltammetric response of INH with consequence additions of
APAP. The calibration curve of APAP was shown in Figure 7B
with the linear relationship from 10 to 210 μmol L−1 with a
linear equation; Ip (μA) = 0.02 μA μM
−1 + 0.083 μA (R2 =
0.997). While, Figure 7C shows DPV of successive additions of
INH in the presence of 50 μmol L−1 APAP. As can see from the
voltammograms, relatively the current response of APAP does
not eﬀect by addition of INH even at high concentrations. A
linear calibration curve for INH additions was presented in
Figure 7D; Ip (μA) = 0.007 μA μM
−1 + 0.937 μA (R2 = 0.97).
The limits of detection of APAP and INH were calculated
based on these linear ﬁtting equations to be 37 nmol L−1 and
1.61 μmol L−1, respectively. These results synergistically proved
the feasibility of simultaneous determination and distinguished
electrochemical sensing performance of BiO-SPEs to APAP and
INH drugs as shown in Table 1.
Repeatability of BiO-SPEs for APAP and INH Deter-
mination. Screen-printed electrode is a favorable approach in
electroanalytical chemistry because it provides a low-cost,
single-shot, disposable, yet highly reproducible and reliable
platform for electrochemical measurement of the target analyte.
However, the sensitivity and selectivity are a major challenge.
Therefore, the modiﬁcation of SPEs with active nanomaterials
or biorecognition events has been developed. The reproduci-
bility of BiO-SPEs was investigated by using the same BiO-
SPEs for ﬁve repetitive measurements of 50 μmol L−1 APAP
and 100 μmol L−1 INH under the optimum conditions. The
relative standard deviation was calculated to be 0.27% and
0.08% for APAP and INH, respectively. Furthermore, BiO-
SPEs show not only reproducible signal on the same electrode
but also with separately employed SPEs. Three electrodes were
examined in the presence of 50 μmol L−1 APAP and 100 μmol
L−1 INH under the same conditions. The relative standard
deviation was calculated to be 1.7% and 2.1% for APAP and
INH drugs, respectively. These results revealed that BiO
nanorods are promising materials in electrochemical determi-
nation of APAP and INH in real samples.
Analysis of Real Samples. To verify the applicability of a
BiO-SPE sensor, the recovery experiment for determination of
APAP and INH in a human serum environment was performed
as in Characterization of Bismuth Oxide Nanostructures. Before
DPV determination, the APAP and INH were spiked into
human serum and left it for 30 min in fridge at 4 °C. Then,
these spiked samples were added to 10 mL electrochemical cell
containing B. R. buﬀer pH 2.0. The concentrations of APAP
and INH were determined by standard addition protocol. The
results were summarized and listed in Table 2. The recovery
experiment for human serum samples demonstrated that the
Figure 6. DPV responses from successive additions of APAP (A) and
INH (C) into B.R. buﬀer pH 2 at BiO nanostructures modiﬁed SPEs.
(B, D) Typical calibration plots corresponding to APAP and INH
additions up to 1800 μM. DPV parameters: step potential 0.01 V,
modulation potential 0.025 V, modulation time 0.05 s, interval time
0.2 s, scan rate 50 mV s−1, deposition time 5 s, and equilibrium time 5
s.
Figure 7. (A) DPV curves from successive addition of APAP in
presence 50 μM INH and (B) corresponding peak current as a
function of APAP concentrations. (C) DPV curves for successive
addition of INH in presence 50 μM APAP and (D) corresponding
peak current as a function of INH concentration. DPV parameters:
step potential 0.01 V, modulation potential 0.025 V, modulation time
0.05 s, interval time 0.2 s, scan rate 50 mV s−1, deposition time 5 s, and
equilibrium time 5 s.
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BiO-SPE electrochemical sensing platforms held great promise
for reliable and sensitive application in the clinical analysis.
Moreover, to explore the applicability of BiO-SPEs in
simultaneous and sensitive determination of APAP and INH,
the recovery experiments were performed in human blood,
urine, and saliva samples. As explained in the Experimental
Section, the APAP and INH were injected to the human ﬂuid
samples and stored at 4 °C in a refrigerator. After 1.0 h, the
human blood was centrifuged for 5 min at 3500 rpm. The
supernatant serum sample containing APAP and INH was
collected in a new test tube and the pH was adjusted to pH 2
by HCl. A 100 μL of treated serum samples was dropped onto
BiO-SPEs cell, DPV was utilized and the standard addition
method was used to determine the APAP and INH
concentrations. On other hand, 300 μL of urine or saliva
samples was injected by APAP and INH and stored at 4 °C in
refrigerator for 1.0 h. The sample solution was adjusted to pH 2
using HCl and dropped onto BiO-SPEs and DPV was utilized.
Further, the APAP and INH were determined in pharmaceut-
ical dosage. The concentrations or “recoveries” of APAP and
INH were obtained. As shown in Figure S5 and Table 3, BiO-
SPEs are promising candidates in determination of APAP and
INH in diﬀerent matrix samples.
■ CONCLUSIONS
A simple and one-pot hydrothermal synthesis of bismuth-rich
bismuth oxide (Bi2O2.33) nanorods has been developed for the
ﬁrst time. The bismuth oxide powder casted onto screen-
printed electrode mutually facilitates the electron transfer and
mass transport as well as electrocatalytic activity toward
oxidation of APAP and INH drugs. The unique properties of
bismuth oxide in terms of porosity, surface area, and nanoscale
dimension oﬀered a remarkable decrease in overvoltage and
improved electrochemical response of APAP and INH drugs.
Furthermore, the BiO-SPEs were applied for the determination
of APAP and INH in human serum with satisfying results,
Table 1. Comparisons of the Proposed Bismuth Oxide-SPEs with Previous Reported Electrochemical Methods for APAP and
INH Determinations
electrode target molecule linear range (μM) LOD (μM) ref
thionine immobilized APAP 0.1−100 0.05 29
MWCNT/CPE INH 1−100 0.8
EGR,ZnO/GCE APAP 0.02−10 33 48
tyrosine/GCE INH 25−125 6.93 49
Fe3O4/PDDA/GR/GCE APAP 0.1−100 0.037 50
AuNP−MWCNT/GCE INH 0.2−10 0.0003 51
MIPRu−AuNP−MCNT/GCE INH 0.1−110 0.08 52
OMC/GC INH 0.1−370 0.084 53
ERGO/GCE INH 2−70 0.17 54
RGO-Au/GCE INH 10−1000 0.01 55
(MWCNT−chit/GCE) INH 10−100 0.055 56
GR/GCE APAP 0.032 57
Au and glutamic acid/CPE APAP 0.05−70 58
GCE APAP 4−100 0.369 59
TiO2-GR/GCE APAP 1−100 0.21 5
BiO-SPEs APAP 0.5−97 0.03 this work
INH 5−100 1.85
Table 2. Determination of APAP and INH Added in Human
Serum Samples Using DPVa
added (μM) detected (μM) recovery (%) ± SDb
blood
serum APAP INH APAP INH APAP INH
sample 1 10 40 9.8 37.2 98 ± 1.94 93 ± 3.15
15 60 15.3 62.4 102 ± 2.04 104 ± 4.17
sample 2 10 40 10.2 39.2 102 ± 1.49 98 ± 2.44
15 60 15.4 55.2 102.7 ± 1.75 92 ± 4.34
aEach sample was measured three times, n = 3. bRelative standard
deviation.
Table 3. Recovery of APAP and INH in Diﬀerent Real Samples Measured by DPV Using a Three-Electrode BiO-SPEs
Conﬁguration Cella
added (mM) detected (mM) recovery (%) ± SDb
sample APAP INH APAP INH APAP INH
human blood 0.25 0.50 0.213 0.475 85 ± 4.04 95 ± 2.10
urine samples 2.0 2.0 2.2 1.96 111 ± 3.09 98 ± 1.04
1.0 4.0 1.09 3.96 109 ± 4.34 99 ± 2.50
0.40 1.50 0.43 1.45 108 ± 3.75 97 ± 2.30
saliva samples 2.0 2.0 2.08 2.04 104 ± 3.2 102 ± 2.01
1.0 3.0 1.08 3.15 108 ± 2.1 105 ± 1.02
pharmaceutical tablets 0.25 0.25 0.245 0.253 98 ± 2.08 101.2 ± 3.2
0.1 0.1 0.103 0.099 103 ± 3.05 99 ± 3.6
aEach sample was measured three times, n = 3. bRelative standard deviation.
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indicating that BiO-SPEs can be a promising electrode material
for on-site determination of APAP and INH drugs.
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